EdgarLookup

RELMADA THERAPEUTICS, INC. — 8-K Filings

143 8-K filings on record

This page lists all 8-K filings submitted to the SEC by RELMADA THERAPEUTICS, INC. (RLMD), sorted by most recent first. Each row links to the full filing on EdgarLookup. RELMADA THERAPEUTICS, INC. has filed 143 8-K documents with the SEC since 2012. To view all SEC filings by RELMADA THERAPEUTICS, INC., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-KT 10-Q 144 3 3/A 4 4/A 424B3 424B5 5 5/A 8-A12B 8-A12G 8-K 8-K/A CERT CORRESP D D/A DEF 14A DEFA14A DFAN14A EFFECT FWP NT 10-K NT 10-Q POS AM PRE 14A S-1 S-1/A S-3 S-3/A S-3ASR S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF ACTION UPLOAD
Form Description Accession Number Filed Period
8-K CURRENT REPORT 0001213900-26-032403 Mar 20, 2026 Mar 19, 2026
8-K CURRENT REPORT 0001213900-26-024918 Mar 9, 2026
8-K CURRENT REPORT 0001213900-25-121461 Dec 15, 2025 Dec 12, 2025
8-K CURRENT REPORT 0001213900-25-110088 Nov 13, 2025
8-K CURRENT REPORT 0001213900-25-106398 Nov 5, 2025 Nov 4, 2025
8-K CURRENT REPORT 0001213900-25-105593 Nov 4, 2025
8-K CURRENT REPORT 0001213900-25-088360 Sep 17, 2025
8-K CURRENT REPORT 0001213900-25-087926 Sep 16, 2025 Sep 15, 2025
8-K CURRENT REPORT 0001213900-25-086389 Sep 10, 2025
8-K CURRENT REPORT 0001213900-25-082910 Sep 2, 2025 Aug 29, 2025
8-K CURRENT REPORT 0001213900-25-073130 Aug 7, 2025
8-K CURRENT REPORT 0001213900-25-066995 Jul 23, 2025 Jul 22, 2025
8-K CURRENT REPORT 0001213900-25-062803 Jul 10, 2025 Jul 7, 2025
8-K CURRENT REPORT 0001213900-25-055334 Jun 18, 2025 Jun 17, 2025
8-K CURRENT REPORT 0001213900-25-047805 May 27, 2025 May 23, 2025
8-K CURRENT REPORT 0001213900-25-042024 May 12, 2025 May 8, 2025
8-K CURRENT REPORT 0001213900-25-035941 Apr 28, 2025
8-K CURRENT REPORT 0001013762-25-003432 Mar 27, 2025
8-K CURRENT REPORT 0001013762-25-002786 Mar 26, 2025 Mar 24, 2025
8-K CURRENT REPORT 0001213900-25-010711 Feb 6, 2025 Feb 3, 2025
8-K CURRENT REPORT 0001213900-25-006727 Jan 27, 2025 Jan 21, 2025
8-K CURRENT REPORT 0001213900-25-001249 Jan 6, 2025 Jan 1, 2025
8-K CURRENT REPORT 0001213900-24-106646 Dec 9, 2024
8-K CURRENT REPORT 0001213900-24-105245 Dec 4, 2024
8-K CURRENT REPORT 0001213900-24-047968 May 30, 2024 May 24, 2024
8-K CURRENT REPORT 0001213900-24-024022 Mar 19, 2024
8-K CURRENT REPORT 0001213900-24-003000 Jan 11, 2024 Jan 5, 2024
8-K CURRENT REPORT 0001213900-24-000999 Jan 4, 2024
8-K CURRENT REPORT 0001213900-24-000858 Jan 3, 2024
8-K CURRENT REPORT 0001213900-23-084735 Nov 8, 2023
8-K CURRENT REPORT 0001013762-23-002985 Oct 11, 2023
8-K CURRENT REPORT 0001013762-23-002900 Oct 10, 2023
8-K CURRENT REPORT 0001013762-23-001391 Oct 4, 2023
8-K CURRENT REPORT 0001213900-23-078049 Sep 20, 2023
8-K CURRENT REPORT 0001213900-23-074165 Sep 6, 2023 Sep 5, 2023
8-K CURRENT REPORT 0001213900-23-065674 Aug 10, 2023
8-K CURRENT REPORT 0001213900-23-064577 Aug 8, 2023
8-K CURRENT REPORT 0001213900-23-043101 May 25, 2023
8-K CURRENT REPORT 0001213900-23-040004 May 15, 2023
8-K CURRENT REPORT 0001213900-23-038577 May 11, 2023
8-K CURRENT REPORT 0001213900-23-030851 Apr 19, 2023
8-K CURRENT REPORT 0001213900-23-022428 Mar 23, 2023
8-K CURRENT REPORT 0001213900-23-019392 Mar 13, 2023 Mar 10, 2023
8-K CURRENT REPORT 0001213900-23-002865 Jan 17, 2023 Jan 12, 2023
8-K CURRENT REPORT 0001213900-23-001518 Jan 9, 2023
8-K CURRENT REPORT 0001213900-23-001162 Jan 5, 2023 Jan 1, 2023
8-K CURRENT REPORT 0001213900-22-083290 Dec 28, 2022 Dec 27, 2022
8-K CURRENT REPORT 0001213900-22-078255 Dec 7, 2022
8-K CURRENT REPORT 0001213900-22-071463 Nov 14, 2022 Nov 11, 2022
8-K CURRENT REPORT 0001213900-22-071296 Nov 10, 2022